Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease, Insulin Sensitivity
Conditions
Keywords
Shift work, Sleep, Blood sugar, Metabolism
Brief summary
Insufficient sleep and circadian misalignment are independent risk factors for the development of obesity and diabetes, yet few strategies exist to counter metabolic impairments when these behaviors are unavoidable. This project will examine whether avoiding food intake during the biological night can mitigate the impact of circadian misalignment on metabolic homeostasis in adults during simulated night shift work. Findings from this study could identify a translatable strategy to minimize metabolic diseases in populations that include anyone working nonstandard hours such as police, paramedics, firefighters, military personnel, pilots, doctors and nurses, truck drivers, and individuals with sleep disorders.
Detailed description
People who work evening, night or rotating shifts (i.e. nonstandard work hours) represent one in five U.S. employees and are alarmingly 44% more likely to develop Type 2 diabetes (T2D) compared to people who work standard day shifts. Circadian misalignment is one mechanism suggested to increases the risk of obesity and diabetes in people who work non-standard hours, and is highly prevalent and often unavoidable in modern, 24-hour society (e.g. shift work, long work hours, jet lag, medical residency, emergency responders, military personnel, Daylight Savings Time changes, etc). Disruptions in sleep and circadian rhythms have been linked to insulin resistance, increased energy intake, weight gain, and increased total body, abdominal and intrahepatic fat content, yet there have been limited attempts at identifying strategies or countermeasures to prevent the impact of such disruption on T2D risk in a sizeable proportion of the population. Therefore, the long-term goal is to identify and develop effective, behavioral countermeasures to combat the increased risk for metabolic diseases associated with sleep and circadian disruption when these behaviors are unavoidable. The overall objective for this project is to test the impact of time-restricted feeding to a 7h period in the day as a noninvasive countermeasure to the metabolic impairments associated with circadian misalignment. The central hypothesis is that time-restricted feeding to the daytime period will prevent metabolic impairments during circadian misalignment compared to a condition where energy is consumed throughout the day and night. The rationale for the proposed project is that defining a non-invasive, scalable and feasible countermeasure to circadian misalignment could mitigate the risk of obesity and T2D. To test the overall hypothesis, a randomized crossover study will be used with a rigorous inpatient diet, activity and light-controlled protocol in healthy men and women. The impact of time restricted feeding during circadian misalignment on metabolic homeostasis will be determined. Findings from this study represent a critical advancement in the fields of translational circadian and metabolic physiology by identifying and testing a countermeasure to circadian misalignment. Achievement of the proposed aims could lead to the development of new intervention strategies for chronic disease prevention and management. The knowledge to be gained offers the potential to support cost-effective programs that may inform healthcare approach to metabolic disease prevention in populations at risk for these diseases such as shift workers, individuals with sleep disorders and anyone who eats outside of daytime hours.
Interventions
BEHAVIORALTime-restricted feeding
Each subject will participate in both conditions (CM and CM+TRF)--one in which food is allowed during the nighttime period and one in which food will be restricted to the daytime only. Food intake will be matched across conditions and designed to keep participants weight stable.
BEHAVIORALCircadian Misalignment
Healthy lean subjects will undergo circadian misalignment induced using a simulated night shift-work protocol in both conditions of the study. Each condition will last approximately 6 days.
Sponsors
University of Colorado, Denver
Salk Institute for Biological Studies
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Colorado State University
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
1. 18-35 old; men and women; equal numbers of women and men will be included. 2. Body Mass Index (BMI) between 20.0 and 24.9 (normal weight). 3. Physical activity history: inactive to habitual moderate physical activity level 4. Sleep/wake history: habitual sleep duration between 7-9.25 hours. 5. Altitude history: Potential subjects must have lived at Denver altitude or higher for at least 3 months prior to inpatient stay.
Exclusion criteria
1. Any clinically significant medical, psychiatric, or sleep disorder 2. Use of prescribed medications/supplements/illicit drugs within one month prior to study 3. History of shift work in year prior to study, or travel more than one time zone in three weeks prior to study. \[NOTE: Subjects can be studied at a later date.\] 4. Women with history of prior gynecological pathology, \<1 year post-partum, breast-feeding and/or pregnant. 5. Non-English speakers will be excluded, as we do not have access to a translator who could rely accurate information to the participant for the consent or throughout the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin sensitivity-derived from glucose tolerance test | Change to be assessed at Day 3, Day 5, Day 31, Day 33. |
| Muscle tissue lipids-assessed by lipidomic analyses | Change to be assessed at Day 3, Day 5, Day 31, Day 33. |
Secondary
| Measure | Time frame |
|---|---|
| 24-hour circulating blood glucose levels-assessed by assay | Change to be assessed at Day 3, Day 5, Day 31, Day 33. |
| 24-hour circulating blood insulin levels-assessed by assay | Change to be assessed at Day 3, Day 5, Day 31, Day 33. |
| 24-hour circulating blood free fatty acid levels-assessed by assay | Change to be assessed at Day 3, Day 5, Day 31, Day 33. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Sleep quality assessments-assessed by Actiwatch | Change to be assessed at Day 2, Day 4, Day 30, Day 32. | movement and light sensor equipment |
| Sleep quality assessments-assessed by Maintenance of Wakefulness Test | Change to be assessed at Day 2, Day 4, Day 30, Day 32. | onset of sleep latency |
| Sleep quality assessments-assessed by Leeds Sleep Evaluation Questionnaire | Change to be assessed at Day 2, Day 4, Day 30, Day 32. | subjective feelings of last night's sleep compared to usual of (1) getting to sleep- (easier, harder), (quicker, slower), (more drowsy, less drowsy); (2) quality of sleep- (more restful, less restful), (few periods of wakefulness, more periods of wakefulness); (3) awakening pattern-(easier, more difficult), (took shorter, took longer); (4) balance and coordination- (less clumsy, more clumsy) |
| Cognitive assessments-Karolinska Sleepiness Scale | Change to be assessed at Day 3, Day 5, Day 31, Day 33. | subjective sleepiness measurement 1-9, 1=Very Alert, 9=Very sleepy, great effort to keep awake, fighting sleep |
| Functional balance-assessed by multi-sensor recorder | Change to be assessed at Day 1, Day 3, Day 29, Day 31. | gyroscope, accelerometer, attitude |
| Systolic and diastolic blood pressure | Change to be assessed at Day 2, Day 4, Day 30, Day 32. | automatic vitals machine |
| Functional grip strength-measured by hand dynamometer | Change to be assessed at Day 2, Day 4, Day 30, Day 32. | average force |
| Cognitive assessments-Positive and Negative Affect Schedule | Change to be assessed at Day 3, Day 5, Day 31, Day 33. | subjective emotions & feelings, Scores range from 10-50 with higher scores represent higher levels of positive affect of 20 emotions & feelings items, and lower scores represent lower levels of negative affect of 20 emotions & feelings items. |
| Cognitive assessments- Psychomotor Vigilance Task | Change to be assessed at Day 3, Day 5, Day 31, Day 33. | reaction time |
| Cognitive assessments- Conjunction Visual Search Task | Change to be assessed at Day 3, Day 5, Day 31, Day 33. | reaction time & error rate |
| Sleep staging-assessed by polysomnography | Change to be assessed at Day 2, Day 4, Day 30, Day 32. | Electrical activity across the scalp will be measured using polysomnography and sleep will be staged as Wake, Stage 1, Stage 2, Stage 3 and REM. |
Countries
United States
Contacts
Primary ContactJosiane L Broussard, PhD
Backup ContactEllen Lyon, MS
Outcome results
None listed